Physician profile
Casey D Taber
NPI 1972711463
$98,229.75
in general payments reported to CMS, 2019-2025
13 companies · $1,533 in 2025
The $1,533 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $797 · 2020: $462 · 2021: $22K · 2022: $27K · 2023: $29K · 2024: $17K · 2025: $1,533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $41K · Travel and Lodging: $4,364 · Food and Beverage: $2,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,875.00 |
| Travel and Lodging | $4,363.70 |
| Food and Beverage | $2,281.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $97,939.43 | 2019-2025 | Mako, Aequalis, Na |
| Depuy Synthes Sales INC. | $58.59 | 2019-2022 | |
| Biocomposites INC | $40.31 | 2024 | |
| Heron Therapeutics, INC. | $33.62 | 2024 | Zynrelef |
| Janssen Pharmaceuticals, INC | $25.98 | 2024 | Xarelto |
| Pacira Therapeutics, INC. | $25.94 | 2019-2020 | |
| Astellas Pharma US INC | $22.13 | 2020 | |
| Vericel Corporation | $21.01 | 2020 | |
| Smith+Nephew, INC. | $20.70 | 2019 | |
| Kci USA, INC. | $20.00 | 2019 | |
| Orthofix Medical, INC. | $12.78 | 2023 | Spinal-Stim, Physio-Stim |
| Heraeus Medical, LLC. | $9.26 | 2023 | Palacos |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Taber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.